{"id":61995,"date":"2025-10-09T01:02:55","date_gmt":"2025-10-08T23:02:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/"},"modified":"2025-10-09T01:02:55","modified_gmt":"2025-10-08T23:02:55","slug":"navidea-biopharmaceuticals-inc-files-for-bankruptcy","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/","title":{"rendered":"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy"},"content":{"rendered":"
\n

\nNavidea Biopharmaceucitals, Inc. files for Bankruptcy<\/i><\/p>\n

<\/a>
<\/a><\/p>\n

COLUMBUS, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (\u201cNavidea\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it filed a voluntary petition for relief under Chapter 11, Subchapter V of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware (the \u201cCourt\u201d) on October 1, 2025.<\/p>\n

\nThe filing is intended to enable the Company to pursue an orderly restructuring of its financial obligations while continuing limited operations to preserve value for creditors and stakeholders. The Company intends to use the Chapter 11 process to evaluate strategic alternatives, protect its assets, and ensure fair treatment of creditors.<\/p>\n

\nAccess to Case Information<\/b><\/p>\n

\nEpiq Corporate Restructuring, LLC (\u201cEpiq\u201d) is serving as the claims and noticing agent for the Company\u2019s Chapter 11 case. Creditors, shareholders, and other interested parties can obtain additional information about the case, including court filings, claim forms, and key dates, by visiting the Epiq website at: https:\/\/dm.epiq11.com\/Navidea<\/a>. Additionally, creditors, shareholders, and other interested parties can register on the case website to receive electronic copies of to all docketed Court pleadings, free of charge.<\/p>\n

\nAbout Navidea<\/b><\/p>\n

\nNavidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics. Navidea is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Navidea\u2019s Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Tc99m tilmanocept, the first product developed and commercialized by Navidea based on the platform. Navidea\u2019s strategy is to market novel products and advancing the Company\u2019s pipeline through global partnering and commercialization efforts through its diverse portfolio of issued US and foreign patents and patent applications. For more information, visit www.navidea.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nCraig A. Dais, Chief Financial Officer
\n
cdais@navidea.com<\/a>
(614)-822-2322<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Navidea Biopharmaceucitals, Inc. files for Bankruptcy COLUMBUS, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (\u201cNavidea\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it filed a voluntary petition for relief under Chapter 11, Subchapter V of the United States Bankruptcy Code in the U.S. Bankruptcy Court for … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61995","6":"format-standard","7":"category-industry"},"yoast_head":"\nNavidea Biopharmaceuticals, Inc. Files for Bankruptcy - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Navidea Biopharmaceucitals, Inc. files for Bankruptcy COLUMBUS, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (\u201cNavidea\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it filed a voluntary petition for relief under Chapter 11, Subchapter V of the United States Bankruptcy Code in the U.S. Bankruptcy Court for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-08T23:02:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251008843839\/en\/389794\/5\/navidea_cmyk.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy\",\"datePublished\":\"2025-10-08T23:02:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/\"},\"wordCount\":349,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251008843839\\\/en\\\/389794\\\/5\\\/navidea_cmyk.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/\",\"name\":\"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251008843839\\\/en\\\/389794\\\/5\\\/navidea_cmyk.jpg\",\"datePublished\":\"2025-10-08T23:02:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251008843839\\\/en\\\/389794\\\/5\\\/navidea_cmyk.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251008843839\\\/en\\\/389794\\\/5\\\/navidea_cmyk.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/","og_locale":"en_US","og_type":"article","og_title":"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy - Pharma Trend","og_description":"Navidea Biopharmaceucitals, Inc. files for Bankruptcy COLUMBUS, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (\u201cNavidea\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that it filed a voluntary petition for relief under Chapter 11, Subchapter V of the United States Bankruptcy Code in the U.S. Bankruptcy Court for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/","og_site_name":"Pharma Trend","article_published_time":"2025-10-08T23:02:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251008843839\/en\/389794\/5\/navidea_cmyk.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy","datePublished":"2025-10-08T23:02:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/"},"wordCount":349,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251008843839\/en\/389794\/5\/navidea_cmyk.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/","url":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/","name":"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251008843839\/en\/389794\/5\/navidea_cmyk.jpg","datePublished":"2025-10-08T23:02:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251008843839\/en\/389794\/5\/navidea_cmyk.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251008843839\/en\/389794\/5\/navidea_cmyk.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/navidea-biopharmaceuticals-inc-files-for-bankruptcy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Navidea Biopharmaceuticals, Inc. Files for Bankruptcy"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61995"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61995\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}